Next-generation protein analysis in the pathology department

13Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Traditionally, immunohistochemistry (IHC) is used by pathologists to localise specific proteins or peptides in tissue slides. In the era of personalised medicine, however, molecular tissue analysis becomes indispensable for correct diagnosis, prognosis and therapeutic decision, not only on the DNA or mRNA level but also on the protein level. Combining molecular information with imaging presents many advantages. Therefore, matrix-assisted laser desorption/ionisation imaging mass spectrometry (MALDI IMS) is a promising technique to be added to the armamentarium of the pathologist. Here, we focus on the workflow, advantages and drawbacks of both MALDI IMS and IHC. We also briefly discuss a few other protein imaging modalities and give examples of applications.

Cite

CITATION STYLE

APA

Ahmed, M., Broeckx, G., Baggerman, G., Schildermans, K., Pauwels, P., Van Craenenbroeck, A. H., & Dendooven, A. (2020, January 1). Next-generation protein analysis in the pathology department. Journal of Clinical Pathology. BMJ Publishing Group. https://doi.org/10.1136/jclinpath-2019-205864

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free